Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells

Blood

Volumn 112, Issue 5, 2008, Pages 1776-1783

  Agaugué, Sophie ^a   Marcenaro, Emanuela ^a   Ferranti, Bruna ^a   Moretta, Lorenzo ^a   Moretta, Alessandro ^a,b,c  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c Laboratory of Biochemistry   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; AUTACOID; IL2 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ARTICLE; CELL INTERACTION; CELL MATURATION; CELL POLARITY; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; CELL COMMUNICATION; CELL CULTURE; CELL DIFFERENTIATION; COCULTURE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; METABOLISM;

CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DENDRITIC CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKINS; KILLER CELLS, NATURAL; MONOCYTES; T-LYMPHOCYTES; TH1 CELLS;

EID: 52649116495     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-135871     Document Type: Article

References (56)

1. Zitvogel L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med. 2002;195:F9-14.
2. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol. 2002;2:957-964.
3. WalzerT, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural-killer cells and dendritic cells: "I'union fait la force." Blood. 2005;106:2252-2258.
4. Kalinski P, Mailliard RB, Giermasz A, et al. Natural killer-dendritic cell cross-talk in cancer immunotherapy. Expert Opin Biol Ther. 2005;5:1303-1315.
5. Banchereau J, Briere F, Gaux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000; 18:767-811.
6. Cooper MA. FehnigerTA. Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001;22:633-640.
7. Cooper MA. FehnigerTA. Fuchs A, Colonna M. Caligiuri MA. NK cell and DC interactions. Trends Immunol. 2004;25:47-52.
8. Ferlazzo G, Tsang ML Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med. 2002;195:343-351.
9. Fernandez NC, Flament C, Crepineau F, Angevin E, Vivier E, Zitvogel L. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. Eur Cytokine Netw. 2002;13:17-27.
10. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med. 2002;195:327-333.
11. Mailliard RB, Son Yl, Redlinger R, et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NKcell helper function. J Immunol. 2003;171: 2366-2373.
12. Munz C, DaoT, Ferlazzo G, de Cos MA, Goodman K, Young JW. Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood. 2005;105:266-273.
13. Pende D, Castriconi R, Romagnani P, et al. expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killerdendritic cell interaction. Blood. 2006; 107:2030-2036.
14. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med. 2002;195:335-341.
15. Vitale M, Delia Chiesa M, Carlomagno S, et al. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood. 2005;106:566-571.
16. - natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol. 2004;34:1715-1722.
17. Moretta L, Ferlazzo G, Bottino C, et al. Effector and regulatory events during natural killerdendritic cell interactions. Immunol Rev. 2006; 214:219-228.
18. Delia Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol. 2003;33:1657-1666.
19. Ferlazzo G, Morandi B, D'Agostino A, et al. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol. 2003;33:306-313.
20. Mailliard RB, Alber SM, Shen H, et al. IL-18-induced CD83+CCR7+ NKhelpercells. J Exp Med. 2005;202:941-953.
21. Marcenaro E, Delia Chiesa M, Bellora F, et al. IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. J Immunol. 2005;174:3992-3998.
22. Agaugue S, Perrin-Cocon L, Coutant F, Andre P, Lotteau V. 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity. J Immunol. 2006;177:2061-2071.
23. Cooper MA, FehnigerTA, Turner SC, et al. Human natural killer cells: a unique innate imrnunoregulatory role for the CD56(bright) subset. Blood. 2001;97:3146-3151.
24. Corthay A. Athree-cell model for activation of naive T helper cells. Scand J Immunol. 2006;64:93-96.
25. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, Lanier LL. NK cell regulation of T cell-mediated responses. Mol Immunol. 2005;42:451-454.
26. Martin-Fontecha A, Thomson LL, Brett S, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol. 2004;5:1260-1265.
27. Mocikat R, Braumuller H, Gumy A, et al. Natural killer cells activated by MHC class I (low) targets prime dendritic cells to induce protective CD8 Tcell responses. Immunity. 2003;19:561-569.
28. Morandi B, Bougras G, Muller WA, Ferlazzo G, Munz C. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. Eur J Immunol. 2006;36:2394-2400.
29. Jenh CH, Cox MA, Kaminski H. et al. Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human SCkine is not a ligand for the human or mouse CXCR3 receptors. J Immunol. 1999;162:3765-3769.
30. Soto H, Wang W, Strieter RM, et al. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc Natl Acad Sci U S A. 1998:95: 8205-8210.
31. Campbell JJ, Qin S, Unutmaz D, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol. 2001; 166:6477-6482.
32. Inngjerdingen M, Damaj B, Maghazachi AA. expression and regulation of chemokine receptors in human natural killer cells. Blood. 2001;97:367-375.
33. FehnigerTA, Cooper MA, Nuovo GJ, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood. 2003:101:3052-3057.
34. Ferlazzo G, Thomas D, Lin SL, et al. The abundant NK cells in human secondary lymphoid tis sues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol. 2004; 172:1455-1462.
35. Moretta A, Marcenaro E, Parolini S, Ferlazzo G, Moretta L. NK cells at the interface between innate and adaptive immunity. Cell Death Differ. 2007.
36. Parolini S, Santoro A, Marcenaro E, et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood. 2007;109:3625-3632.
37. Falcone FH, Zillikens D, Gibbs BF. The 21st century renaissance of the basophil? Current insights into its role in allergic responses and innate immunity. Exp Dermatol. 2006:15:855-864.
38. Malaviya R, Georges A. Regulation of mast cell-mediated innate immunity during early response to bacterial infection. Clin Rev Allergy Immunol. 2002;22:189-204.
39. Moretta A, Marcenaro E, Sivori S, Delia Chiesa M, Vitale M, Moretta L. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol. 2005;26: 668-675.
40. Granucci F Feau S, Angeli V, Trottein F Ricciardi-Castagnoli P. Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming. J Immunol. 2003:170:5075-5081.
41. Granucci F, Vizzardelli C, Pavelka N, et al. Induc-ible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol. 2001;2:882-888.
42. Feau S, Facchinetti V, Granucci F, et al. Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice. Blood. 2005;105:697-702.
43. Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: an overview. Methods Mol Biol. 2006; 315:13-34.
44. Parker LG, Prince LR, Sabroe I. Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity. Clin Exp Immunol. 2007; 147:199-207.
45. Parker LC, Whyte MK, Dower SK, Sabroe I. The expression and roles of Toll-like receptors in the biology of the human neutrophil. J Leukoc Biol. 2005:77:886-892.
46. Phipps S, Lam CE, Foster PS, Matthaei Kl. The contribution of toll-like receptors to the pathogenesis of asthma. Immunol Cell Biol. 2007;85:463-470.
47. Joshi PC, Zhou X, Cuchens M, Jones Q. Prosta-glandin E2 suppressed IL-15-mediated human NK cell function through down-regulation of common gamma-chain. J Immunol. 2001;166:885-891.
48. Krause P, Singer E, Darley PI, Klebensberger J, Groettrup M, Legler DF. Prostaglandin E2 is a key factor for rnonocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO. J Leukoc Biol. 2007;82:1106-1114.
49. Rubio MT, Means TK, Chakraverty R, et al. Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs. Int Immunol. 2005;17:1561-1572.
50. Castriconi R, Cantoni C, Delia Chiesa M, et al. Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A. 2003;100:4120-4125.
51. Geissmann F, Revy P, Regnault A, et al. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol. 1999;162:4567-4575.
52. McBride JM, Jung T, de Vries JE, Aversa G. IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. Cell Immunol. 2002;215:162-172.
53. Steinbrink K, Graulich E, Kubsch S, Knop J, Enk AH. CD4(+)and CD8(+) anergicTcells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood. 2002;99:2468-2476.
54. Steinbrink K, Jonuleit H, Muller G, Schuler G, Knop J, Enk AH. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood. 1999;93:1634-1642.
55. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol. 1997;159:4772-4780.
56. Mocellin S, Panelli M, Wang E, et al. IL-10 stimulatory effects on human NK cells explored by gene profile analysis. Genes Immun. 2004;5:621-630.